Cardiovascular safety of 5-fluorouracil and capecitabine in colorectal cancer patients: real-world evidence
Abstract Background Fluoropyrimidines, including 5-fluorouracil and capecitabine, are the most common chemotherapeutic agents for colorectal carcinoma. Although previous studies have suggested varying degrees of cardiotoxicity with these drugs, there is a notable lack of large-scale investigations w...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2025-01-01
|
| Rangatū: | Cardio-Oncology |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s40959-024-00294-2 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
